These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2354828)

  • 1. Urinary gonadotropin fragment, a new tumor marker. III. Use in cervical and vulvar cancers.
    Nam JH; Chang KC; Chambers JT; Schwartz PE; Cole LA
    Gynecol Oncol; 1990 Jul; 38(1):66-70. PubMed ID: 2354828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary gonadotropin fragment (UGF) measurements in the diagnosis and management of ovarian cancer.
    Cole LA; Nam JH
    Yale J Biol Med; 1989; 62(4):367-78. PubMed ID: 2596125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary gonadotropin fragment, a new tumor marker. IV. Use in endometrial cancers and uterine mixed mullerian tumors.
    Nam JH; Chambers JT; Schwartz PE; Cole LA
    Gynecol Oncol; 1990 Dec; 39(3):352-7. PubMed ID: 2175287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
    Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
    Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. I. Sensitivity and specificity, comparison with other markers.
    Cole LA; Schwartz PE; Wang YX
    Gynecol Oncol; 1988 Sep; 31(1):82-90. PubMed ID: 3044936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report.
    Cole LA; Tanaka A; Kim GS; Park SY; Koh MW; Schwartz PE; Chambers JT; Nam JH
    Gynecol Oncol; 1996 Feb; 60(2):264-70. PubMed ID: 8631549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. II. Initial serial studies.
    Wang YX; Schwartz PE; Chambers JT; Cole LA
    Gynecol Oncol; 1988 Sep; 31(1):91-102. PubMed ID: 3410359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary gonadotropin fragment, a new tumor marker. I. Assay development and cancer specificity.
    Nam JH; Cole LA; Chambers JT; Schwartz PE
    Gynecol Oncol; 1990 Mar; 36(3):383-90. PubMed ID: 2318449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary gonadotropin fragment, a new tumor marker. II. Differentiating a benign from a malignant pelvic mass.
    Cole LA; Nam JH; Chambers JT; Schwartz PE
    Gynecol Oncol; 1990 Mar; 36(3):391-4. PubMed ID: 2318450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical applications of urinary gonadotropin peptides (UGP) in gynecologic oncology.
    Schwartz PE; Cracchiolo BM; Cole LA
    Anticancer Res; 1996; 16(4B):2135-9. PubMed ID: 8694533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum squamous cell carcinoma antigen in gynecologic malignancies with special reference to cervical cancer.
    Hsieh CY; Chang DY; Huang SC; Yen ML; Juang GT; Ouyang PC
    Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):797-800. PubMed ID: 2592943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of the SCC antigen in the serum of patients with cervical cancer].
    Crombach G; Würz H; Bolte A
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
    Geyer H; Schwörer D; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):266-71. PubMed ID: 2721888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrence.
    Rose PG; Baker S; Fournier L; Nelson BE; Hunter RE
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):942-6. PubMed ID: 8456907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squamous cell carcinoma antigen in cervical cancer.
    Borras G; Molina R; Xercavins J; Ballesta A; Iglesias X
    Eur J Gynaecol Oncol; 1992; 13(5):414-8. PubMed ID: 1486921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of squamous cell carcinoma antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer.
    Hefler L; Obermair A; Tempfer C; van Houte M; Maenner G; Reinthaller A; Leodolter S; Kainz C
    Int J Cancer; 1999 Jun; 84(3):299-303. PubMed ID: 10371350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary gonadotropin fragment measurements in patients with lung and esophageal disease.
    D'Agostino RS; Cole LA; Ponn RB; Stern H; Schwartz PE
    J Surg Oncol; 1992 Mar; 49(3):147-50. PubMed ID: 1548888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
    Crombach G; Würz H; Herrmann F; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G; Caffier H; Kaesemann H
    Dtsch Med Wochenschr; 1989 May; 114(18):700-5. PubMed ID: 2714197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of urinary beta-core fragment of hCG as a tumor marker of cervical cancer].
    Kinugasa M; Nishimura R; Hasegawa K; Okamura M; Kimura A; Ohtsu F; Takeuchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):188-94. PubMed ID: 1545171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous cell carcinoma antigen for monitoring cervical cancer.
    Schmidt-Rhode P; Schulz KD; Sturm G; Häfner H; Prinz H; Künzig HJ
    Int J Biol Markers; 1988; 3(2):87-94. PubMed ID: 3243981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.